ALG3 and hepatocellular carcinoma: This study, by integrating bioinformatic analyses, multiplex immunohistochemistry, and patient-derived organoid models, for the first time reveals the critical role of ALG3, a key enzyme involved in endoplasmic reticulum glycosylation—in reshaping the HCC immune microenvironment and mediating resistance to PD-1 blockade.